| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.9B | $21.3B | $19.4B | $17.1B | $17.8B | $18.2B | $6.8B | $6.2B |
| Cost of Revenue | $16.2B | $15.8B | $14.3B | $12.1B | $12.4B | $12.9B | $4.5B | $3.9B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.4B | $3.6B | $3.3B | $3.0B | $3.3B | $3.3B | — | — |
| Operating Income | $2.1B | $1.9B | $1.4B | $1.8B | $3.3B | — | — | $1.1B |
| Net Income | $1.6B | $1.5B | $1.2B | $1.1B | $1.8B | $1.1B | $0.9B | $0.7B |
| EPS (Basic) | $8.57 | $7.91 | $6.47 | $5.54 | $9.17 | $5.23 | $8.03 | $6.04 |
| EPS (Diluted) | $8.53 | $7.87 | $6.44 | $5.49 | $9.09 | $5.19 | $7.86 | $5.92 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $41.2B | $42.0B | $41.7B | $33.5B | $34.7B | $37.0B | $10.1B | $9.8B |
| Current Assets | $8.6B | $8.2B | $8.1B | $6.8B | $6.4B | $6.7B | $2.6B | $2.2B |
| Cash & Equivalents | $1.1B | $0.6B | $0.6B | $0.9B | $0.9B | $1.3B | $0.5B | $0.3B |
| Total Liabilities | $21.6B | $22.4B | $22.9B | — | — | — | — | — |
| Current Liabilities | $7.2B | $7.6B | $8.0B | $5.8B | $4.6B | $4.2B | $2.3B | $1.8B |
| Stockholders' Equity | $19.6B | $19.5B | $18.8B | $18.5B | $19.2B | $20.7B | $3.4B | $3.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.1B | $2.6B | $2.1B | $2.2B | $2.7B | $2.8B | $1.2B | $0.8B |
| Investing Cash Flow | $0.4B | $-0.3B | $-7.0B | $-0.3B | $1.4B | $0.8B | $-0.2B | $-0.1B |
| Capital Expenditures | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.4B | $0.2B | $0.1B |
| Financing Cash Flow | $-3.1B | $-2.2B | $4.6B | $-2.0B | $-4.4B | $-3.1B | $-0.8B | $-0.8B |